AAAAAA
Results:
1-22
|
Results: 22
Authors:
Schlicker, E
Kathmann, M
Citation: E. Schlicker et M. Kathmann, Modulation of transmitter release via presynaptic cannabinoid receptors, TRENDS PHAR, 22(11), 2001, pp. 565-572
Authors:
Malinowska, B
Piszcz, J
Koneczny, B
Hryniewicz, A
Schlicker, E
Citation: B. Malinowska et al., Modulation of the cardiac autonomic transmission of pithed rats by presynaptic opioid OP4 and cannabinoid CB1 receptors, N-S ARCH PH, 364(3), 2001, pp. 233-241
Authors:
Schlicker, E
Kozlowska, H
Kwolek, G
Malinowska, B
Kramer, K
Pertz, HH
Elz, S
Schunack, W
Citation: E. Schlicker et al., Novel histaprodifen analogues as potent histamine H-1-receptor agonists inthe pithed and in the anaesthetized rat, N-S ARCH PH, 364(1), 2001, pp. 14-20
Authors:
Fischer, W
Kittner, H
Regenthal, R
Malinowska, B
Schlicker, E
Citation: W. Fischer et al., Anticonvulsant and sodium channel blocking activity of higher doses of clenbuterol, N-S ARCH PH, 363(2), 2001, pp. 182-192
Authors:
Kathmann, M
Weber, B
Schlicker, E
Citation: M. Kathmann et al., Cannabinoid CB1 receptor-mediated inhibition of acetylcholine release in the brain of NMRI, CD-1 and C57BL/6J mice, N-S ARCH PH, 363(1), 2001, pp. 50-56
Authors:
Weber, B
Schlicker, E
Sokoloff, P
Stark, H
Citation: B. Weber et al., Identification of the dopamine autoreceptor in the guinea-pig retina as D-2 receptor using novel subtype-selective antagonists, BR J PHARM, 133(8), 2001, pp. 1243-1248
Authors:
Nickel, T
Bauer, U
Schlicker, E
Kathmann, M
Gothert, M
Sasse, A
Stark, H
Schunack, W
Citation: T. Nickel et al., Novel histamine H-3-receptor antagonists and partial agonists with a non-aminergic structure, BR J PHARM, 132(8), 2001, pp. 1665-1672
Authors:
Kathmann, M
Weber, B
Zimmer, A
Schlicker, E
Citation: M. Kathmann et al., Enhanced acetylcholine release in the hippocampus of cannabinoid CB1 receptor-deficient mice, BR J PHARM, 132(6), 2001, pp. 1169-1173
Authors:
Schlicker, E
Morari, M
Citation: E. Schlicker et M. Morari, Nociceptin/orphanin FQ and neurotransmitter release in the central nervoussystem, PEPTIDES, 21(7), 2000, pp. 1023-1029
Authors:
Malinowska, B
Kozlowska, H
Berger, H
Schlicker, E
Citation: B. Malinowska et al., Acetyl-RYYRIK-NH2 is a highly efficacious OP4 receptor agonist in the cardiovascular system of anesthetized rats, PEPTIDES, 21(12), 2000, pp. 1875-1880
Authors:
Nakazi, M
Bauer, U
Nickel, T
Kathmann, M
Schlicker, E
Citation: M. Nakazi et al., Inhibition of serotonin release in the mouse brain via presynaptic cannabinoid CB1 receptors, N-S ARCH PH, 361(1), 2000, pp. 19-24
Authors:
Malinowska, B
Kozlowska, H
Koneczny, B
Schlicker, E
Citation: B. Malinowska et al., Nociceptin inhibits the neurogenic vasopressor response in the pithed rat via prejunctional ORL1 receptors, N-S ARCH PH, 361(1), 2000, pp. 80-84
Authors:
Molderings, GJ
Menzel, S
Kathmann, M
Schlicker, E
Gothert, M
Citation: Gj. Molderings et al., Dual interaction of agmatine with the rat alpha(2D)-adrenoceptor: competitive antagonism and allosteric activation, BR J PHARM, 130(7), 2000, pp. 1706-1712
Authors:
Schlicker, E
Werthwein, S
Zentner, J
Citation: E. Schlicker et al., Histamine H-3 receptor-mediated inhibition of noradrenaline release in thehuman brain, FUN CL PHAR, 13(1), 1999, pp. 120-122
Authors:
Kathmann, M
Bauer, U
Schlicker, E
Citation: M. Kathmann et al., CB1 receptor density and CB1 receptor-mediated functional effects in rat hippocampus are decreased by an intracerebroventricularly administered antisense oligodeoxynucleotide, N-S ARCH PH, 360(4), 1999, pp. 421-427
Authors:
Kathmann, M
Bauer, U
Schlicker, E
Gothert, M
Citation: M. Kathmann et al., Cannabinoid CB1 receptor-mediated inhibition of NMDA- and kainate-stimulated noradrenaline and dopamine release in the brain, N-S ARCH PH, 359(6), 1999, pp. 466-470
Authors:
Malinowska, B
Piszcz, J
Schlicker, E
Kramer, K
Elz, S
Schunack, W
Citation: B. Malinowska et al., Histaprodifen, methylhistaprodifen, and dimethylhistaprodifen are potent H-1-receptor agonists in the pithed and in the anaesthetized rat, N-S ARCH PH, 359(1), 1999, pp. 11-16
Authors:
Bauer, U
Nakazi, M
Kathmann, M
Gothert, M
Schlicker, E
Citation: U. Bauer et al., The stereoselective kappa-opioid receptor antagonist Mr2266 does not exhibit stereoselectivity as an antagonist at the orphan opioid (ORL1) receptor, N-S ARCH PH, 359(1), 1999, pp. 17-20
Authors:
Middlemiss, DN
Gothert, M
Schlicker, E
Scott, CM
Selkirk, JV
Watson, J
Gaster, LM
Wyman, P
Riley, G
Price, GW
Citation: Dn. Middlemiss et al., SB-236057, a selective 5-HT1B receptor inverse agonist, blocks the 5-HT human terminal autoreceptor, EUR J PHARM, 375(1-3), 1999, pp. 359-365
Authors:
Werthwein, S
Bauer, U
Nakazi, M
Kathmann, M
Schlicker, E
Citation: S. Werthwein et al., Further characterization of the ORL1 receptor-mediated inhibition of noradrenaline release in the mouse brain in vitro, BR J PHARM, 127(1), 1999, pp. 300-308
Authors:
Schlicker, E
Kathmann, M
Citation: E. Schlicker et M. Kathmann, Modulation of in vitro neurotransmission in the CNS and in the retina via H-3 heteroreceptors, PHARMCHEM L, 30, 1998, pp. 13-26
Authors:
Kathmann, M
Schlicker, E
Marr, L
Werthwein, S
Stark, H
Schunack, W
Citation: M. Kathmann et al., Ciproxifan and chemically related compounds are highly potent and selective histamine H-3-receptor antagonists, N-S ARCH PH, 358(6), 1998, pp. 623-627
Risultati:
1-22
|